Atrovent and Xgeva drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Atrovent (ipratropium bromide) and Xgeva (denosumab). Common drug interactions include pallor among females and constipation among males.
The phase IV clinical study analyzes what interactions people have when they take Atrovent and Xgeva. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.
What is Atrovent?
Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.
What is Xgeva?
Xgeva has active ingredients of denosumab. It is often used in breast cancer. eHealthMe is studying from 37,717 Xgeva users. Check the latest studies of Xgeva.
31 people who take Atrovent and Xgeva together, and have interactions are studied.

What are the common drug interactions of Atrovent and Xgeva, by gender? *:
female:
- Pallor
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Pelvic venous thrombosis (blood clot occurring inside a blood vessel and thromboses (dvts) that form in the deep veins of the legs or in the pelvic veins)
- Pharyngeal inflammation
- Pneumonia
- Pyrexia (fever)
- Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
- Renal failure (kidney dysfunction)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Thrombocytopenia (decrease of platelets in blood)
male:
- Constipation
- Malignant neoplasm progression (cancer tumour came back)
- Abdominal distension
- Abdominal pain
- Asthenia (weakness)
- Cardiac failure
- Cardiac failure congestive
- Chest discomfort
- Coagulopathy (blood's ability to clot is impaired)
- Cor pulmonale acute (rapid enlargement of the right ventricle of the heart)
What are the common drug interactions of Atrovent and Xgeva, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Diarrhoea
- Fatigue (feeling of tiredness)
- Malignant neoplasm progression (cancer tumour came back)
- Renal failure (kidney dysfunction)
40-49:
- Cor pulmonale acute (rapid enlargement of the right ventricle of the heart)
- Dyspnoea (difficult or laboured respiration)
- Hepatitis (inflammation of the liver)
- Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
- Pharyngeal inflammation
- Thrombocytopenia (decrease of platelets in blood)
- Pulmonary oedema (fluid accumulation in the lungs)
- Tumour haemorrhage (bleeding from tumour)
- C-reactive protein increased
- White blood cell count increased
50-59:
- Anaemia (lack of blood)
- Asthenia (weakness)
- Chest pain
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Enterocolonic fistula
- Fatigue (feeling of tiredness)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypokalaemia (low potassium)
- Large intestine perforation (hole in large intestine)
60+:
- Malignant neoplasm progression (cancer tumour came back)
- Arthralgia (joint pain)
- Oxygen saturation decreased
- Pain in extremity
- Photopsia (presence of perceived flashes of light)
- Anaemia of chronic disease
- Breast cancer stage iv
- Chest pain
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Dyspnoea (difficult or laboured respiration)
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 8 people, 25.81%
- Pain: 6 people, 19.35%
- Dyspnea (difficult or laboured breathing): 5 people, 16.13%
- Breast Cancer Metastatic: 4 people, 12.90%
- Multiple Myeloma (cancer of the plasma cells): 4 people, 12.90%
- Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 12.90%
- Wheezing (a high-pitched whistling sound made while you breath): 3 people, 9.68%
- Cancer Pain: 3 people, 9.68%
- Cough: 3 people, 9.68%
- Anaemia (lack of blood): 3 people, 9.68%
* Approximation only. Some reports may have incomplete information.
Do you take Atrovent and Xgeva?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Atrovent and Xgeva:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Atrovent:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Xgeva:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Atrovent and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xgeva and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ipratropium bromide and denosumab (the active ingredients of Atrovent and Xgeva, respectively), and Atrovent and Xgeva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Etoposide cause Clostridium Difficile Colitis? - now
- Sprintec vs. Aspirin, side effect and effectiveness comparison - 11 seconds ago
- Could Pred Forte cause Sinusitis? - 15 seconds ago
- Could Pred Forte cause Sinusitis - Acute? - 15 seconds ago
- Drug interactions of Amlodipine and Mesalamine - 28 seconds ago
- Fibromyalgia and Thrombosis - 39 seconds ago
- Acetaminophen vs. Alcohol, side effect and effectiveness comparison - 42 seconds ago
- Hydrocortone vs. Omeprazole, side effect and effectiveness comparison - 43 seconds ago
- Cartia Xt vs. Omeprazole, side effect and effectiveness comparison - a minute ago
- Could Enbrel cause Kidney Transplant? - a minute ago